These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2054270)

  • 1. Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia.
    Bowes SG; Clark PK; Charlett A; O'Neill CJ; Leeman AL; Weller C; Nicholson PW; Deshmukh AA; Dobbs SM; Dobbs RJ
    Br J Clin Pharmacol; 1991 Mar; 31(3):295-304. PubMed ID: 2054270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy.
    Bowes SG; Clark PK; Leeman AL; O'Neill CJ; Weller C; Nicholson PW; Deshmukh AA; Dobbs SM; Dobbs RJ
    Br J Clin Pharmacol; 1990 Jul; 30(1):13-24. PubMed ID: 2202385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopa.
    Bowes SG; Dobbs RJ; Henley M; Charlett A; O'Neill CJ; Nicholson PW; Purkiss AG; Weller C; Dobbs SM
    Eur J Clin Pharmacol; 1992; 43(5):483-9. PubMed ID: 1483485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.
    Weller C; O'Neill CJ; Charlett A; Bowes SG; Purkiss A; Nicholson PW; Dobbs RJ; Dobbs SM
    Br J Clin Pharmacol; 1993 Apr; 35(4):379-85. PubMed ID: 8485018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
    Ondo WG; Shinawi L; Moore S
    Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
    Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
    Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in the stride length-cadence relation in parkinsonian gait.
    Morris M; Iansek R; Matyas T; Summers J
    Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.
    Stocchi F; Hsu A; Khanna S; Ellenbogen A; Mahler A; Liang G; Dillmann U; Rubens R; Kell S; Gupta S
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1335-40. PubMed ID: 25306200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait variability in Parkinson's disease: levodopa and walking direction.
    Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
    Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonian abnormality of foot strike: a phenomenon of ageing and/or one responsive to levodopa therapy?
    Hughes JR; Bowes SG; Leeman AL; O'Neill CJ; Deshmukh AA; Nicholson PW; Dobbs SM; Dobbs RJ
    Br J Clin Pharmacol; 1990 Feb; 29(2):179-86. PubMed ID: 2306409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor response to levodopa in fluctuating Parkinson's disease.
    Moore ST; MacDougall HG; Gracies JM; Ondo WG
    Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.
    Ferreira F; Gago MF; Bicho E; Carvalho C; Mollaei N; Rodrigues L; Sousa N; Rodrigues PP; Ferreira C; Gama J
    J Biomech; 2019 Jul; 92():98-104. PubMed ID: 31182234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of Sinemet CR4 in patients with Parkinson's disease.
    Anderson TJ; Ewer TC; Gilchrist NL; Donaldson IM
    N Z Med J; 1992 Mar; 105(929):81-2. PubMed ID: 1545941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
    Rochester L; Baker K; Nieuwboer A; Burn D
    Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in spatiotemporal gait characteristics over the course of the L-dopa cycle in people with advanced Parkinson disease .
    MacKay-Lyons M
    Phys Ther; 1998 Oct; 78(10):1083-94. PubMed ID: 9781702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.
    Bryant MS; Rintala DH; Hou JG; Lai EC; Protas EJ
    NeuroRehabilitation; 2011; 29(3):247-52. PubMed ID: 22142758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-release levodopa/carbidopa. III: Sinemet CR5 treatment of response fluctuations in Parkinson's disease.
    Cedarbaum JM; Hoey M; Kutt H; McDowell FH
    Clin Neuropharmacol; 1988 Apr; 11(2):168-73. PubMed ID: 3378225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease.
    Verhagen Metman L; Stover N; Chen C; Cowles VE; Sweeney M
    Mov Disord; 2015 Aug; 30(9):1222-8. PubMed ID: 25847690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.